Literature DB >> 23353716

Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys).

Louis J Gooren1, Tanapong Sungkaew, Erik J Giltay.   

Abstract

Transgender people sometimes use cross-sex hormones without medical supervision. The use of cross-sex hormones, as well as the functional health and mental well-being, among male-to-female transgendered people ('kathoeys') in Chiang Mai, Thailand, was studied. Sixty kathoeys were interviewed regarding their use of cross-sex hormones and their family relationships. Individuals also completed the Life Orientation Test Revised (LOT-R) to assess dispositional optimism, the Social Functioning Questionnaire (SFQ) and the Short Form Health Survey 36 (SF-36). Three categories were established as follows: those who never cross-dress, those who sometimes cross-dress and those who always cross-dress in public. Of the 60 subjects, 44 had used hormones for prolonged periods (9.7±6.1 years). Their use was related to the permanence of cross-dressing but unrelated to functional health and mental well-being. Fifty percent of subjects had overdosed on commonly used oral contraceptives. Three people used injectable oestrogen in a higher-than-recommended dose. Self-acceptance was high or reasonably good (83%) compared to no acceptance (17%), and neither was related to the permanence of cross-dressing. Their acceptance by parents and siblings was also relatively high (85% and 89%, respectively). The permanence of cross-dressing had no effect on the scores of optimism, SF-36 scores and social functioning. Acceptance by oneself or one's parents did not seem to affect most aspects of functional health and mental well-being, but non-acceptance by siblings generated lower scores on the social functioning and general mental health subscales. Stressors tended to include physical rather than social factors. In conclusion, the unsupervised use of cross-sex hormones was common among kathoeys, and 50% of the sample had overdosed on them. Acceptance was relatively good, except by siblings. New strategies are needed for a more responsible use of cross-sex hormones.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353716      PMCID: PMC3739151          DOI: 10.1038/aja.2012.139

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  18 in total

Review 1.  Transsexualism: a review of etiology, diagnosis and treatment.

Authors:  P T Cohen-Kettenis; L J Gooren
Journal:  J Psychosom Res       Date:  1999-04       Impact factor: 3.006

Review 2.  Gender identity development and issues.

Authors:  Kenneth J Zucker
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2004-07

Review 3.  Clinical practice. Care of transsexual persons.

Authors:  Louis J Gooren
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

4.  Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test.

Authors:  M F Scheier; C S Carver; M W Bridges
Journal:  J Pers Soc Psychol       Date:  1994-12

5.  A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.

Authors:  Henk Asscheman; Erik J Giltay; Jos A J Megens; W Pim de Ronde; Michael A A van Trotsenburg; Louis J G Gooren
Journal:  Eur J Endocrinol       Date:  2011-01-25       Impact factor: 6.664

6.  Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Authors:  W M Hopman; T Towheed; T Anastassiades; A Tenenhouse; S Poliquin; C Berger; L Joseph; J P Brown; T M Murray; J D Adachi; D A Hanley; E Papadimitropoulos
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

7.  Sex reassignment surgery in Thailand.

Authors:  Prayuth Chokrungvaranont; Preecha Tiewtranon
Journal:  J Med Assoc Thai       Date:  2004-11

8.  HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand.

Authors:  Thomas E Guadamuz; Wipas Wimonsate; Anchalee Varangrat; Praphan Phanuphak; Rapeepun Jommaroeng; Janet M McNicholl; Philip A Mock; Jordan W Tappero; Frits van Griensven
Journal:  AIDS Behav       Date:  2011-04

9.  17 Alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells.

Authors:  R B Dickson; A J Eisenfeld
Journal:  Endocrinology       Date:  1981-04       Impact factor: 4.736

10.  Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

Authors:  A W F T Toorians; M C L G D Thomassen; S Zweegman; E J P Magdeleyns; G Tans; L J G Gooren; J Rosing
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

View more
  11 in total

1.  'For me… it's a miracle': Injecting beauty among kathoeis in a provincial Thai city.

Authors:  Panoopat Poompruek; Pimpawun Boonmongkon; Thomas E Guadamuz
Journal:  Int J Drug Policy       Date:  2014-06-25

2.  Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand.

Authors:  Louis J Gooren; Tanapong Sungkaew; Erik J Giltay; Thomas E Guadamuz
Journal:  Cult Health Sex       Date:  2014-10-01

Review 3.  Providing comprehensive health services for young key populations: needs, barriers and gaps.

Authors:  Sinead Delany-Moretlwe; Frances M Cowan; Joanna Busza; Carolyn Bolton-Moore; Karen Kelley; Lee Fairlie
Journal:  J Int AIDS Soc       Date:  2015-02-26       Impact factor: 5.396

Review 4.  Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices.

Authors:  Asa Radix; Jae Sevelius; Madeline B Deutsch
Journal:  J Int AIDS Soc       Date:  2016-07-17       Impact factor: 5.396

5.  Spermatogenesis Abnormalities following Hormonal Therapy in Transwomen.

Authors:  Sirachai Jindarak; Kasama Nilprapha; Taywin Atikankul; Apichai Angspatt; Pornthep Pungrasmi; Seree Iamphongsai; Pasu Promniyom; Poonpissamai Suwajo; Gennaro Selvaggi; Preecha Tiewtranon
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

6.  Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study.

Authors:  Akarin Hiransuthikul; Rena Janamnuaysook; Kanittha Himmad; Stephen J Kerr; Narukjaporn Thammajaruk; Tippawan Pankam; Kannapat Phanjaroen; Stephen Mills; Ravipa Vannakit; Praphan Phanuphak; Nittaya Phanuphak
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

7.  Hormone use among Nepali transgender women: a qualitative study.

Authors:  Pramod R Regmi; Edwin van Teijlingen; Sanjeev Raj Neupane; Sujan Babu Marahatta
Journal:  BMJ Open       Date:  2019-10-22       Impact factor: 2.692

8.  Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.

Authors:  Lucas Foster Skewis; Ingrid Bretherton; Shalem Y Leemaqz; Jeffrey D Zajac; Ada S Cheung
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-29       Impact factor: 5.555

9.  Sex Partnership and Self-Efficacy Influence Depression in Chinese Transgender Women: A Cross-Sectional Study.

Authors:  Xiaoshi Yang; Lie Wang; Chun Hao; Yuan Gu; Wei Song; Jian Wang; Margaret M Chang; Qun Zhao
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Determinants of and Barriers to Hormonal and Surgical Treatment Receipt Among Transgender People.

Authors:  R Craig Sineath; Cory Woodyatt; Travis Sanchez; Shawn Giammattei; Theresa Gillespie; Enid Hunkeler; Ashli Owen-Smith; Virginia P Quinn; Douglas Roblin; Robert Stephenson; Patrick S Sullivan; Vin Tangpricha; Michael Goodman
Journal:  Transgend Health       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.